The White House has abandoned any real effort to control costs in the pharma sector and Democrats have taken this hands-off approach as a green light to side with Big Pharma.
Read Whole Story
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.